MedTrace Logo

Early Detection of COVID-19 Using Breath Analysis

NCT04602884 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-02-07

No results posted yet for this study

Summary

EARLY DETECTION OF COVID-19 USING BREATH ANALYSIS- FIRST CROSS-SECTIONAL STUDY

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

Breath biopsy sampling using the ReCIVA Breath Sampler

Breath biopsy sampling using the ReCIVA Breath Sampler

Sponsors & Collaborators

  • Scentech Medical Technologies Ltd

    lead INDUSTRY

Principal Investigators

  • Natalie Dror, PhD · Scentech Medical Technologies Ltd

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-22
Primary Completion
2021-12-30
Completion
2021-12-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04602884 on ClinicalTrials.gov